Overview
Analysis Key terms
About CHEPLAPHARM Arzneimittel GmbH 5.5% 15-JAN-2028
Sector
Health Technology
Industry
Pharmaceuticals: Major
Home page
FIGI
BBG00XRR73R5
Cheplapharm Arzneimittel GmbH engages in the development and manufacture of pharmaceutical products. The firm offers medicinal products for sleeping disorders, leukemia, hepatobiliary disorders, alcohol withdrawal, and connective tissue disorders. The company was founded by Kurt Teubner in 1998 and is headquartered in Greifswald, Germany.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.